The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Ocular Immune Privilege and Transplantation
Open accessAbstract
Allografts are afforded a level of protection from rejection within immune-privileged tissues. Immune-privileged tissues involve mechanisms that suppress inflammation and promote immune tolerance. There are anatomical features, soluble factors, membrane-associated proteins, and alternative antigen-presenting cells (APC) that contribute to allograft survival in the immune-privileged tissue. This review presents the current understanding of how the mechanism of ocular immune privilege promotes tolerogenic activity by APC, and T cells in response to the placement of foreign antigen within the ocular microenvironment. Discussed will be the unique anatomical, cellular, and molecular mechanisms that lessen the chance for graft destroying immune responses within the eye. As more is understood about the molecular mechanisms of ocular immune privilege greater is the potential for using these molecular mechanisms in therapies to prevent allograft rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807
Taylor, A. W. (2009) · Eye · doi:10.1038/eye.2008.382 · Cited by 253
Self-citationB7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts
Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., & Azuma, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5928 · Cited by 208
Turnover of resident retinal microglia in the normal adult mouse
Xu, H., Chen, M., Mayer, E. J., Forrester, J. V., & Dick, A. D. (2007) · Glia · doi:10.1002/glia.20535 · Cited by 153 · cited 2×
“Invest Ophthalmol Vis Sci (1998) 39(12):2384–93.”
Thrombospondin Plays a Vital Role in the Immune Privilege of the Eye
Zamiri, P., Masli, S., Kitaichi, N., Taylor, A. W., & Streilein, J. W. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0362 · Cited by 143
Self-citationMicrogliosis: the questions shape the answers
Ransohoff, R. M. (2007) · Nature Neuroscience · doi:10.1038/nn1207-1507 · Cited by 109
Immune regulation and the eye.
Stein-Streilein, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.002 · Cited by 99
Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye
Cousins, S. W., Trattler, W. B., & Streilein, J. W. (1991) · Current Eye Research · doi:10.3109/02713689108996334 · Cited by 85
Research works printed but not linked: 91
- Medawar, 1948, Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain to subcutaneous tissue, and to the anterior chamber of the eye, Br J Exp Pathol, 29, 58
- Barker, 1968, The role of afferent lymphatics in the rejection of skin homografts, J Exp Med, 128, 197, 10.1084/jem.128.1.197 · DOI · Paper page
- McMenamin, 1992, Class II major histocompatibility complex (Ia) antigen-bearing dendritic cells within the iris and ciliary body of the rat eye: distribution, phenotype, and relation to retinal microglia, Immunology, 77, 385
- Paques, 2010, In vivo observation of the locomotion of microglial cells in the retina, Glia, 58, 1663, 10.1002/glia.21037 · DOI
- Hamrah, 2007, Corneal antigen-presenting cells, Chem Immunol Allergy, 92, 58, 10.1159/000099254 · DOI · Paper page
- Knickelbein, 2009, Stratification of antigen-presenting cells within the normal cornea, Ophthalmol Eye Dis, 1, 45, 10.4137/OED.S2813 · DOI
- Hamrah, 2002, Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells, Invest Ophthalmol Vis Sci, 43, 639
- Albini, 2005, Microglial stability and repopulation in the retina, Br J Ophthalmol, 89, 901, 10.1136/bjo.2004.060293 · DOI
- Dullforce, 2004, APCs in the anterior uveal tract do not migrate to draining lymph nodes, J Immunol, 172, 6701, 10.4049/jimmunol.172.11.6701 · DOI
- Chen, 2002, Distribution, markers, and functions of retinal microglia, Ocul Immunol Inflamm, 10, 27, 10.1076/ocii.10.1.27.10328 · DOI · Paper page
- Kaneko, 2008, Characteristics of bone marrow-derived microglia in the normal and injured retina, Invest Ophthalmol Vis Sci, 49, 4162, 10.1167/iovs.08-1738 · DOI
- Ajami, 2007, Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nat Neurosci, 10, 1538, 10.1038/nn2014 · DOI · Paper page
- Eter, 2008, In vivo visualization of dendritic cells, macrophages, and microglial cells responding to laser-induced damage in the fundus of the eye, Invest Ophthalmol Vis Sci, 49, 3649, 10.1167/iovs.07-1322 · DOI
- McMenamin, 1995, Endotoxin-induced uveitis. Kinetics and phenotype of the inflammatory cell infiltrate and the response of the resident tissue macrophages and dendritic cells in the iris and ciliary body, Invest Ophthalmol Vis Sci, 36, 1949
- Campbell, 2012, The blood-retina barrier: tight junctions and barrier modulation, Adv Exp Med Biol, 763, 70, 10.1007/978-1-4614-4711-5_3 · DOI · Paper page
- Taylor, 1992, Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor, Curr Eye Res, 11, 1199, 10.3109/02713689208999545 · DOI · Paper page
- Taylor, 1994, Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor, J Immunol, 153, 1080, 10.4049/jimmunol.153.3.1080 · DOI · Paper page
- Goslings, 1998, Small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation, Invest Ophthalmol Vis Sci, 39, 989
- Taylor, 1998, Suppression of nitric oxide generated by inflammatory microphages by calcitonin gene-related peptide in aqueous humor, Invest Ophthalmol Vis Sci, 39, 1372
- Taylor, 2003, Somatostatin is an imunosuppressive factor in aqueous humor, Invest Ophthalmol Vis Sci, 44, 2644, 10.1167/iovs.02-1216 · DOI
- Zamiri, 2006, Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation, Invest Ophthalmol Vis Sci, 47, 3912, 10.1167/iovs.05-1267 · DOI
- Zamiri, 2007, Thrombospondin plays a vital role in the immune privilege of the eye, Ocul Immunol Inflamm, 15, 279, 10.1080/09273940701382432 · DOI
- Kawanaka, 2011, Localized retinal neuropeptide regulation of macrophage and microglial cell functionality, J Neuroimmunol, 232, 17, 10.1016/j.jneuroim.2010.09.025 · DOI
- Apte, 1998, Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege, J Immunol, 160, 5693, 10.4049/jimmunol.160.12.5693 · DOI · Paper page
- D’Orazio, 1999, Effect of aqueous humor on apoptosis of inflammatory cell types, Invest Ophthalmol Vis Sci, 40, 1418
- Wenkel, 2000, Evidence that retinal pigment epithelium functions as an immune-privileged tissue, Invest Ophthalmol Vis Sci, 41, 3467
- Ishida, 2003, Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms, Ocul Immunol Inflamm, 11, 91, 10.1076/ocii.11.2.91.15914 · DOI
- Sugita, 2006, B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells, Invest Ophthalmol Vis Sci, 47, 5376, 10.1167/iovs.05-1354 · DOI
- Kawazoe, 2012, Retinoic acid from retinal pigment epithelium induces T regulatory cells, Exp Eye Res, 94, 32, 10.1016/j.exer.2011.11.002 · DOI
- Sugita, 2006, Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta, Exp Eye Res, 83, 1459, 10.1016/j.exer.2006.08.005 · DOI
- Sugita, 2009, Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions, J Immunol, 183, 5013, 10.4049/jimmunol.0901623 · DOI
- Sugita, 2009, T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions, Invest Ophthalmol Vis Sci, 50, 2862, 10.1167/iovs.08-2846 · DOI
- Sugita, 2009, Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism, Invest Ophthalmol Vis Sci, 50, 263, 10.1167/iovs.08-2536 · DOI
- Bora, 1993, Differential expression of the complement regulatory proteins in the human eye, Invest Ophthalmol Vis Sci, 34, 3579
- Niederkorn, 2010, History and physiology of immune privilege, Ocul Immunol Inflamm, 18, 19, 10.3109/09273940903564766 · DOI
- Streilein, 1980, Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens, J Exp Med, 152, 1121, 10.1084/jem.152.4.1121 · DOI
- Jiang, 1990, Immunologic privilege evoked by histoincompatible intracameral retinal transplants, Reg Immunol, 3, 121
- Niederkorn, 2003, The immune privilege of corneal grafts, J Leukoc Biol, 74, 167, 10.1189/jlb.1102543 · DOI
- Liu, 2002, Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts, J Exp Med, 195, 259, 10.1084/jem.20010838 · DOI · Paper page
- Sano, 1997, Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in “high-risk” eyes, Curr Eye Res, 16, 1171, 10.1076/ceyr.16.11.1171.5109 · DOI
- Ma, 1998, Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts, Invest Ophthalmol Vis Sci, 39, 2384
- Streilein, 2002, Immunobiology and privilege of neuronal retina and pigment epithelium transplants, Vision Res, 42, 487, 10.1016/S0042-6989(01)00185-7 · DOI · Paper page
- Kaplan, 1975, Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells, J Immunol, 115, 805, 10.4049/jimmunol.115.3.805 · DOI
- Kaplan, 1977, Immune response to immunization via the anterior chamber of the eye. I. F. Lymphocyte-induced immune deviation, J Immunol, 118, 809, 10.4049/jimmunol.118.3.809 · DOI
- Wenkel, 1999, Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space, Invest Ophthalmol Vis Sci, 40, 3202
- Sonoda, 2005, The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation, Immunology, 116, 390, 10.1111/j.1365-2567.2005.02239.x · DOI · Paper page
- Lin, 2005, The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance, J Exp Med, 201, 1615, 10.1084/jem.20042307 · DOI · Paper page
- Streilein, 1981, Induction of anterior chamber-associated immune deviation requires an intact, functional spleen, J Exp Med, 153, 1058, 10.1084/jem.153.5.1058 · DOI · Paper page
- Hsu, 2014, Ex-vivo tolerogenic F4/80(+) antigen-presenting cells (APC) induce efferent CD8(+) regulatory T cell-dependent suppression of experimental autoimmune uveitis, Clin Exp Immunol, 176, 37, 10.1111/cei.12243 · DOI
- Wilbanks, 1992, Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta, Eur J Immunol, 22, 1031, 10.1002/eji.1830220423 · DOI · Paper page
- Hara, 1993, Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type, J Immunol, 151, 5162, 10.4049/jimmunol.151.10.5162 · DOI
- Wilbanks, 1992, Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta, Eur J Immunol, 22, 165, 10.1002/eji.1830220125 · DOI · Paper page
- Faunce, 2002, NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance, J Immunol, 169, 31, 10.4049/jimmunol.169.1.31 · DOI
- D’Orazio, 1998, Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID), Immunology, 95, 47, 10.1046/j.1365-2567.1998.00581.x · DOI
- Sonoda, 2002, Ocular immune privilege and CD1d-reactive natural killer T cells, Cornea, 21, S33, 10.1097/00003226-200203001-00008 · DOI
- Wilbanks, 1990, Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations, Immunology, 71, 383
- Jiang, 2009, Splenic CD8+ T cells secrete TGF-beta1 to exert suppression in mice with anterior chamber-associated immune deviation, Graefes Arch Clin Exp Ophthalmol, 247, 87, 10.1007/s00417-008-0947-8 · DOI
- Paunicka, 2012, Role of IFN-gamma in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells, J Leukoc Biol, 91, 475, 10.1189/jlb.0311173 · DOI
- Sonoda, 2002, CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance, Eur J Immunol, 32, 848, 10.1002/1521-4141(200203)32:3848::AID-IMMU8483.0.CO;2-I · doi:10.1002/1521-4141(200203)32:3848::aid-immu8483.0.co;2-i
- Sonoda, 2002, Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells, J Immunol, 168, 2028, 10.4049/jimmunol.168.4.2028 · DOI
- Masli, 2002, Expression of thrombospondin in TGFbeta-treated APCs and its relevance to their immune deviation-promoting properties, J Immunol, 168, 2264, 10.4049/jimmunol.168.5.2264 · DOI
- Streilein, 1990, Aqueous humor factors and their effect on the immune response in the anterior chamber, Curr Eye Res, 9, 175, 10.3109/02713689008999439 · doi:10.3109/02713689008999439
- Kim, 1988, Intraocular trafficking of lymphocytes in locally induced experimental autoimmune uveoretinitis (EAU), Cell Immunol, 112, 430, 10.1016/0008-8749(88)90312-7 · doi:10.1016/0008-8749(88)90312-7
- Chan, 1988, Dynamics of experimental autoimmune uveoretinitis induced by adoptive transfer of S-antigen-specific T cell line, Invest Ophthalmol Vis Sci, 29, 411
- Cousins, 1991, Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor, Invest Ophthalmol Vis Sci, 32, 2201
- Connor, 1989, Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye, J Clin Invest, 83, 1661, 10.1172/JCI114065 · DOI · Paper page
- Jampel, 1990, Transforming growth factor-beta in human aqueous humor, Curr Eye Res, 9, 963, 10.3109/02713689009069932 · DOI · Paper page
- Knisely, 1991, Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells, Curr Eye Res, 10, 761, 10.3109/02713689109013870 · DOI
- Kaiser, 1989, Inhibition of lymphocyte proliferation by aqueous humor, Reg Immunol, 2, 42
- Taylor, 2009, Review of the activation of TGF-beta in immunity, J Leukoc Biol, 85, 29, 10.1189/jlb.0708415 · DOI · Paper page
- Taylor, 2007, Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. 1997, Ocul Immunol Inflamm, 15, 215, 10.1080/09273940701382234 · DOI
- Lau, 2009, The immune privileged retina mediates an alternative activation of J774A.1 cells, Ocul Immunol Inflamm, 17, 380, 10.3109/09273940903118642 · DOI
- Lee, 2013, Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice, J Immunol, 191, 4103, 10.4049/jimmunol.1300182 · DOI
- Stuart, 1997, CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival, J Clin Invest, 99, 396, 10.1172/JCI119173 · DOI · Paper page
- Griffith, 1995, Fas ligand-induced apoptosis as a mechanism of immune privilege, Science, 270, 1189, 10.1126/science.270.5239.1189 · DOI · Paper page
- Weiss, 2011, Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells, J Immunol, 187, 1684, 10.4049/jimmunol.1002321 · DOI
- Francisco, 2010, The PD-1 pathway in tolerance and autoimmunity, Immunol Rev, 236, 219, 10.1111/j.1600-065X.2010.00923.x · DOI · Paper page
- Copland, 2007, Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis, Am J Pathol, 171, 580, 10.2353/ajpath.2007.070272 · DOI
- Marvel, 2015, Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected, J Clin Invest, 125, 3356, 10.1172/JCI80005 · DOI · Paper page
- Crook, 2015, Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease, J Leukoc Biol, 97, 573, 10.1189/jlb.4A0314-139R · DOI
- Li, 2015, Myeloid-derived suppressor cells suppress CD4(+) and CD8(+) T cell responses in autoimmune hepatitis, Mol Med Rep, 12, 3667, 10.3892/mmr.2015.3791 · DOI
- Jiang, 1991, Immune responses elicited by transplantation and tissue-restricted antigens expressed on retinal tissues implanted subconjunctivally, Transplantation, 52, 513, 10.1097/00007890-199109000-00025 · DOI
- Jiang, 2010, Laser injury promotes migration and integration of retinal progenitor cells into host retina, Mol Vis, 16, 983
- Ross, 1991, The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts, Transplantation, 52, 857, 10.1097/00007890-199111000-00020 · doi:10.1097/00007890-199111000-00020
- Wenkel, 1998, Analysis of immune deviation elicited by antigens injected into the subretinal space, Invest Ophthalmol Vis Sci, 39, 1823
- Qiao, 2009, Retinal laser burn disrupts immune privilege in the eye, Am J Pathol, 174, 414, 10.2353/ajpath.2009.080766 · DOI
- Ng, 2007, Creating an immune-privileged site using retinal progenitor cells and biodegradable polymers, Stem Cells, 25, 1552, 10.1634/stemcells.2006-0780 · doi:10.1634/stemcells.2006-0780
- Taylor, 2001, In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH), Immunol Cell Biol, 79, 358, 10.1046/j.1440-1711.2001.01022.x · DOI
- Ng, 2007, In vitro generated autoimmune regulatory T cells enhance intravitreous allogeneic retinal graft survival, Invest Ophthalmol Vis Sci, 48, 5112, 10.1167/iovs.07-0175 · DOI
- Hamrah, 2009, Local treatment with alpha-melanocyte stimulating hormone reduces corneal allorejection, Transplantation, 88, 180, 10.1097/TP.0b013e3181ac11ea · doi:10.1097/tp.0b013e3181ac11ea
- Taylor, 2010, Applications of the role of alpha-MSH in ocular immune privilege, Adv Exp Med Biol, 681, 143, 10.1007/978-1-4419-6354-3_12 · DOI
Cited by
Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges
Yamanaka, S. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.09.014 · Cited by 1,213
Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)
Ratajczak, W., Rył, A., Mizerski, A., Walczakiewicz, K., Sipak, O., & Laszczyńska, M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2648 · Cited by 514
CNS Infection and Immune Privilege
Forrester, J. V., McMenamin, P. G., & Dando, S. J. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0070-8 · Cited by 313
AAV cis -regulatory sequences are correlated with ocular toxicity
Xiong, W., Wu, D. M., Xue, Y., Wang, S. K., Chung, M. J., Ji, X., Rana, P., Zhao, S. R., Mai, S., & Cepko, C. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821000116 · Cited by 249
Bucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
Metadata
- Authors
- Taylor, A. W.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2016-02-08
- Volume
- 7
- Pages
- 37-37
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2292805097
- Cited by
- 171
- References
- 10
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ocular Immune Privilege and Transplantation. https://app.cochat.ai/papers/10.3389/fimmu.2016.00037
- The paper
- Taylor, A. W. (2016). Ocular Immune Privilege and Transplantation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2016.00037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.